Atomix Pharmaceuticals Inc. is a Toronto-based biotech startup focused on developing novel therapeutic formulations for clinical conditions with a high unmet need. The founders are pharmacists who have leveraged their knowledge and expertise to develop a proprietary topical cream with promising results in a highly prevalent therapeutic area.

Atomix’s formulation is patent-pending and is undergoing clinical trials.

Investors and other interested parties can contact the company at info@atomixpharma.com.